Both in Pharmaceuticals
Nurix Therapeutics vs Ultragenyx Pharmaceutical
Over the past year NRIX returned +30.1% and RARE returned −47.1%; their daily moves had a correlation of 0.12.
NRIX +30.1% RARE −47.1%Growth of $1, one year, split-adjusted
| Metric | NRIX | RARE |
|---|---|---|
| Price | $15.95 | $17.16 |
| Market cap | $1.74B | $1.69B |
| Today | −38.23% | +3.19% |
| 1 month | −29.4% | +18.7% |
| 6 months | −5.5% | −33.8% |
| Year to date | −15.9% | −25.4% |
| 1 year | +26.4% | −48.7% |
| Revenue growth (YoY) | +8426.3% | +28.1% |
| Gross margin | 100.0% | 84.1% |
| Net margin | 81.7% | −43.0% |
| P/E (TTM) | 5.9× | — |
| Price / sales | 2.5× | 2.4× |
| Net cash | $1.05B | $292.0M |
| Dividend yield | — | — |
| Volatility (60d) | 104.6% | 128.5% |
| Short % of float | 21.0% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).